ACKR3 and non-small cell lung carcinoma: Becker and colleagues found that CXCR7 silencing not only re-sensitized EGFR TKI in NSCLC with a mesenchymal phenotype and EGFR mutation, but also promoted partial mesenchymal transition to the epithelium 109.